Hypertension Among Hemorrhagic Stroke Patients in Northeast China: A Population-Based Study 2017–2019

Hui, Dong; Liu, Shuang; Li, Jing; Tian, Mengyuan; Sun, Jinglun; Pang, Yanmin; Xing, Liying; Xu, Yingying

doi:10.12659/msm.926581

Cited by 6 publications

(2 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Denmark, the prevalence of hypertension in the ICH population rose to 66% in the period between 2004 and 2017, probably because of the absence of an appropriate therapy or a suboptimal strategy in most patients ( 35 ). In northeast China, the high number of patients with inadequate pressure control has been correlated with significant stroke incidence ( 36 ). Regarding the relationship between alcohol exposure and stroke, an alcohol dehydrogenase genotype 1B (ADH1B, rs1229984), heterozygous or homozygous in drinks consumers, has been associated with an increased ICH risk ( 37 ).…”

Section: Discussionmentioning

confidence: 99%

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation

Lucà

Colivicchi

Oliva

et al. 2023

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Intracranial hemorrhage (ICH) is considered a potentially severe complication of oral anticoagulants (OACs) and antiplatelet therapy (APT). Patients with atrial fibrillation (AF) who survived ICH present both an increased ischemic and bleeding risk. Due to its lethality, initiating or reinitiating OACs in ICH survivors with AF is challenging. Since ICH recurrence may be life-threatening, patients who experience an ICH are often not treated with OACs, and thus remain at a higher risk of thromboembolic events. It is worthy of mention that subjects with a recent ICH and AF have been scarcely enrolled in randomized controlled trials (RCTs) on ischemic stroke risk management in AF. Nevertheless, in observational studies, stroke incidence and mortality of patients with AF who survived ICH had been shown to be significantly reduced among those treated with OACs. However, the risk of hemorrhagic events, including recurrent ICH, was not necessarily increased, especially in patients with post-traumatic ICH. The optimal timing of anticoagulation initiation or restarting after an ICH in AF patients is also largely debated. Finally, the left atrial appendage occlusion option should be evaluated in AF patients with a very high risk of recurrent ICH. Overall, an interdisciplinary unit consisting of cardiologists, neurologists, neuroradiologists, neurosurgeons, patients, and their families should be involved in management decisions. According to available evidence, this review outlines the most appropriate anticoagulation strategies after an ICH that should be adopted to treat this neglected subset of patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation

Lucà

Colivicchi

Oliva

et al. 2023

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

“…26 Hypertension is the most common risk factor for hemorrhagic stroke. 27 Most anesthetics induce hypotension, so they are unlikely to provoke hemorrhagic stroke while under anesthesia. 28 However, if postoperative hypertension persists for several hours, it can lead to certain condition linked to a sudden surge of cerebral perfusion.…”

Section: Hemorrhagic Strokementioning

confidence: 99%